Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.
Aspeslagh, S., Nemcovic, M., Pauwels, N., Venken, K., Wang, J., Van Calenbergh, S., Zajonc, D.M., Elewaut, D.(2013) J Immunol 191: 2916-2925
- PubMed: 23960235 
- DOI: 10.4049/jimmunol.1203134
- Primary Citation of Related Structures:  
4IRS, 4IRJ - PubMed Abstract: 
NKT cells, a unique type of regulatory T cells, respond to structurally diverse glycolipids presented by CD1d. Although it was previously thought that recognition of glycolipids such as α-galactosylceramide (α-GalCer) by the NKT cell TCR (NKTCR) obey ...